Drug-Spending Cuts Dropped From Budget-Caps Deal

By John Wilkerson, Rachel Cohrs / July 22, 2019 at 1:17 PM
The Trump administration seems to have dropped the $115 billion in drug-spending cuts pushed by the White House on Friday (July 19), restoring the politics of the drug-pricing debate to its previous level of complication. The White House reportedly now seeks $75 billion in separate offsets, which Bloomberg reports comprise extending budget caps on Medicare and imposing customs fees. But the $115 billion in drug-spending cuts proposed Friday are still of interest because the measures pushed by the White...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.